Erratum: Efbemalenograstim Alfa, a Long-Acting Granulocyte Colony-Stimulating Factor Fusion Protein Without PEGylation, Versus Pegfilgrastim for Management of Chemotherapy-Induced Neutropenia in Patients With Breast Cancer: Results of a Phase III Randomized Noninferiority Trial
Year: 2025
Type: erratum
Source: JCO oncology advances.
DOI: 10.1200/oa-25-00048
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4409416426
